Neuronetics, Inc.
STIMNeuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How STIM's past catalysts played out
No drugs found in this phase.
Frequently asked questions
When is Neuronetics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Neuronetics, Inc. (STIM) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track STIM biotech catalysts?→
Add STIM to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Neuronetics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.